跳至主要内容
临床试验/NCT04597177
NCT04597177Unknown不适用

Swallowing Sparing IMRT (SW-IMRT) Versus Standard Parotid Sparing IMRT (ST-IMRT) in the Treatment of Head and Neck Cancer

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2015年9月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
146
试验地点
1
主要终点
Objective assessment of the swallowing function (dysphagia) at regular intervals

研究概览

简要总结

To clinically validate whether SW-IMRT actually reduce the occurrence of swallowing dysfunction as compared to ST-IMRT.

详细描述

Patients are randomly assigned to either ST-IMRT or SW-IMRT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with squamous cell carcinoma and requiring whole neck irradiation as a part of either definitive RT alone or in combination with chemotherapy or post-operative RT either alone or in combination with chemotherapy.

排除标准

  • Previous radiotherapy to the head and neck region or prior malignancies, and/or distant metastases.

结局指标

主要结局

Objective assessment of the swallowing function (dysphagia) at regular intervals

时间窗: 6 months

Objective assessment of swallowing will be made by videofluoroscopy and scored by Dynamic Imaging Grade of swallowing toxicity scale (DIGEST) and will be scored on a scale of 0 (no dysphagia) to 4 (life threatening )

Subjective assessment of the swallowing function (dysphagia) at regular intervals

时间窗: 6 months

Subjective assessment of swallowing function (dysphagia) will be scored on a scale of 0 (no dysphagia) to 4 (life threatening consequences; urgent intervention indicated) each follow-up visit on the basis of National Cancer Institute Common Terminology Criteria for Adverse Events, version 4 (CTCAE 4).

次要结局

  • local control(6 months)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验